1. Home
  2. MBIO vs DEVS Comparison

MBIO vs DEVS Comparison

Compare MBIO & DEVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MBIO
  • DEVS
  • Stock Information
  • Founded
  • MBIO 2015
  • DEVS N/A
  • Country
  • MBIO United States
  • DEVS Canada
  • Employees
  • MBIO N/A
  • DEVS N/A
  • Industry
  • MBIO Biotechnology: Pharmaceutical Preparations
  • DEVS
  • Sector
  • MBIO Health Care
  • DEVS
  • Exchange
  • MBIO Nasdaq
  • DEVS NYSE
  • Market Cap
  • MBIO 7.3M
  • DEVS 6.1M
  • IPO Year
  • MBIO N/A
  • DEVS N/A
  • Fundamental
  • Price
  • MBIO $1.12
  • DEVS $0.53
  • Analyst Decision
  • MBIO Strong Buy
  • DEVS
  • Analyst Count
  • MBIO 1
  • DEVS 0
  • Target Price
  • MBIO $100.00
  • DEVS N/A
  • AVG Volume (30 Days)
  • MBIO 1.1M
  • DEVS 42.7M
  • Earning Date
  • MBIO 05-27-2025
  • DEVS 05-27-2025
  • Dividend Yield
  • MBIO N/A
  • DEVS N/A
  • EPS Growth
  • MBIO N/A
  • DEVS N/A
  • EPS
  • MBIO N/A
  • DEVS N/A
  • Revenue
  • MBIO N/A
  • DEVS N/A
  • Revenue This Year
  • MBIO N/A
  • DEVS N/A
  • Revenue Next Year
  • MBIO N/A
  • DEVS N/A
  • P/E Ratio
  • MBIO N/A
  • DEVS N/A
  • Revenue Growth
  • MBIO N/A
  • DEVS N/A
  • 52 Week Low
  • MBIO $1.01
  • DEVS $0.18
  • 52 Week High
  • MBIO $65.00
  • DEVS $1.91
  • Technical
  • Relative Strength Index (RSI)
  • MBIO 36.90
  • DEVS N/A
  • Support Level
  • MBIO $1.01
  • DEVS N/A
  • Resistance Level
  • MBIO $1.22
  • DEVS N/A
  • Average True Range (ATR)
  • MBIO 0.07
  • DEVS 0.00
  • MACD
  • MBIO 0.02
  • DEVS 0.00
  • Stochastic Oscillator
  • MBIO 52.38
  • DEVS 0.00

About MBIO Mustang Bio Inc.

Mustang Bio Inc is a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs in cell and gene therapy into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline is currently focused on the core areas of gene therapies for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies, and CAR T therapies for solid tumors.

About DEVS DEVVSTREAM CORP

DevvStream Corp is a technology-based ESG company that advances the development and monetization of environmental assets, with an initial focus on carbon markets. It works with governments and corporations to achieve its sustainability goals through the implementation of curated green technology projects that generate renewable energy, improve energy efficiencies, eliminate or reduce emissions, and sequester carbon directly from the air.

Share on Social Networks: